Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma

Journal of Gastroenterology

Volumn 45, Issue 2, 2010, Pages 146-152

  Utsunomiya, Tohru ^a,b   Shimada, Mitsuo ^b   Imura, Satoru ^b   Morine, Yuji ^b   Ikemoto, Tetsuya ^b   Mori, Masaki ^c  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA microarray; Gene expression profile; Hepatocarcinogenesis; Multicentric recurrence

Indexed keywords

COMPLEMENTARY DNA;

CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; EARLY CANCER; GENE EXPRESSION PROFILING; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MULTIPLE CANCER; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK;

EID: 77949265477     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0164-1     Document Type: Review

References (43)

1. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917 10.1016/S0140-6736(03)14964-1 14667750 (Pubitemid 37518510)
2. K Koike 2009 Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection J Gastroenterol 44 82 88 10.1007/s00535-008-2276-4 19148799
3. S Sherlock 1994 Viruses and hepatocellular carcinoma Gut 35 828 832 10.1136/gut.35.6.828 1:STN:280:DyaK2c3pt1Sitw%3D%3D 8020813
4. K Tarao Y Rino S Ohkawa A Shimizu S Tamai K Miyakaswa, et al. 1999 Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis Cancer 86 589 595 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K 1:CAS:528:DyaK1MXlslSmtr0%3D 10440686 (Pubitemid 29379404)
5. M Sakamoto 2009 Early HCC: diagnosis and molecular markers J Gastroenterol 44 108 111 10.1007/s00535-008-2245-y 1:CAS:528: DC%2BD1MXosVKjsA%3D%3D 19148803
6. T Utsunomiya T Matsumata E Adachi H Honda K Sugimachi 1992 Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma Hepatology 16 694 701 10.1002/hep.1840160313 1:STN:280:DyaK38zntF2ntw%3D%3D 1324215
7. M Shimada K Takenaka T Gion Y Fujiwara K Kajiyama T Maeda, et al. 1996 Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan Gastroenterology 111 720 726 10.1053/gast.1996.v111.pm8780578 1:STN:280:DyaK28znsVartQ%3D%3D 8780578
8. T Utsunomiya M Shimada KI Taguchi H Hasegawa Y Yamashita T Hamatsu, et al. 2000 Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma J Am Coll Surg 190 331 335 10.1016/S1072-7515(99) 00268-9 1:STN:280:DC%2BD3c7ms1Khtw%3D%3D 10703859 (Pubitemid 30118392)
9. N Iizuka M Oka H Yamada Okabe M Nishida Y Maeda N Mori, et al. 2003 Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 923 929 10.1016/S0140-6736(03)12775-4 1:CAS:528:DC%2BD3sXitVKmtLg%3D 12648972 (Pubitemid 36332108)
10. Y Kurokawa R Matoba I Takemasa H Nagano K Dono S Nakamori, et al. 2004 Molecular-based prediction of early recurrence in hepatocellular carcinoma J Hepatol 41 284 291 10.1016/j.jhep.2004.04.031 1:CAS:528:DC%2BD2cXmt1KjsLg%3D 15288478 (Pubitemid 39177633)
11. MC Ho JJ Lin CN Chen CC Chen H Lee CY Yang, et al. 2006 A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach Ann Surg Oncol 13 1474 1484 10.1245/s10434-006-9057-1 17009164 (Pubitemid 44749659)
12. SM Wang LL Ooi KM Hui 2007 Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma Clin Cancer Res 13 6275 6283 10.1158/1078-0432.CCR-06-2236 1:CAS:528: DC%2BD2sXht1Cgtb7L 17975138 (Pubitemid 350075015)
13. HG Woo ES Park JH Cheon JH Kim JS Lee BJ Park, et al. 2008 Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma Clin Cancer Res 14 2056 2064 10.1158/1078-0432.CCR-07- 1473 1:CAS:528:DC%2BD1cXkt1akurc%3D 18381945 (Pubitemid 351551116)
14. H Somura N Iizuka T Tamesa K Sakamoto T Hamaguchi R Tsunedomi, et al. 2008 A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy Oncol Rep 19 489 495 1:CAS:528: DC%2BD1cXitV2ksbg%3D 18202799
15. S Yoshioka I Takemasa H Nagano N Kittaka T Noda H Wada, et al. 2009 Molecular prediction of early recurrence after resection of hepatocellular carcinoma Eur J Cancer 45 881 889 10.1016/j.ejca.2008.12.019 1:CAS:528:DC%2BD1MXisl2rsb0%3D 19167881
16. RT Poon ST Fan IO Ng CM Lo CL Liu J Wong 2000 Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 500 507 10.1002/1097-0142(20000801)89: 3<500::AID-CNCR4>3.0.CO;2-O 1:STN:280:DC%2BD3cvgt1aktg%3D%3D 10931448 (Pubitemid 30640096)
17. K Takenaka E Adachi T Nishizaki K Hiroshige T Ikeda M Tsuneyoshi, et al. 1994 Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study Hepatology 19 889 894 10.1002/hep.1840190414 1:STN:280:DyaK2c7os1WltQ%3D%3D 8138262
18. T Kumada S Nakano I Takeda K Sugiyama T Osada S Kiriyama, et al. 1997 Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma Hepatology 25 87 92 10.1002/hep.510250116 1:STN:280:DyaK2s7jvVantg%3D%3D 8985270
19. JW Kim Q Ye M Forgues, et al. 2004 Cancer-associated molecular signature in the tissue samples of patients with cirrhosis Hepatology 39 518 527 10.1002/hep.20053 1:CAS:528:DC%2BD2cXjtlaitb0%3D 14768006 (Pubitemid 38222194)
20. T Utsunomiya M Okamoto S Wakiyama M Hashimoto K Fukuzawa T Ezaki, et al. 2006 Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients Ann Surg Oncol 13 947 954 10.1245/ASO.2006.07.018 16788756 (T. Utsunomiya, M. Okamoto: equal contribution) (Pubitemid 43920927)
21. A Budhu M Forgues QH Ye HL Jia P He KA Zanetti, et al. 2006 Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 99 111 10.1016/j.ccr.2006.06.016 1:CAS:528:DC%2BD28XovVKqur0%3D 16904609 (Pubitemid 44202603)
22. N Iizuka Y Hamamoto R Tsunedomi M Oka 2008 Translational microarray systems for outcome prediction of hepatocellular carcinoma Cancer Sci 99 659 665 10.1111/j.1349-7006.2008.00751.x 1:CAS:528:DC%2BD1cXls1Sksrk%3D 18377418
23. Y Hoshida A Villanueva M Kobayashi J Peix DY Chiang A Camargo, et al. 2008 Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 1995 2004 10.1056/NEJMoa0804525 1:CAS:528:DC%2BD1cXhtleisrzE 18923165
24. VR Mas RA Fisher KJ Archer KC Yanek B Williams CI Dumur, et al. 2007 Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results Transplantation 83 973 981 10.1097/01.tp.0000258643.05294.0b 17460570 (Pubitemid 46682740)
25. M Kudo 2009 Multistep human hepatocarcinogenesis: correlation of imaging with pathology J Gastroenterol 44 112 118 10.1007/s00535-008-2274-6 19148804
26. NJ Torok 2008 Recent advances in the pathogenesis and diagnosis of liver fibrosis J Gastroenterol 43 315 321 10.1007/s00535-008-2181-x 1:CAS:528:DC%2BD1cXnvFSms7s%3D 18592147 (Pubitemid 351958893)
27. T Utsunomiya M Okamoto M Hashimoto K Yoshinaga T Shiraishi F Tanaka, et al. 2004 A gene-expression signature can quantify the degree of hepatic fibrosis in the rat J Hepatol 41 399 406 10.1016/j.jhep.2004.05.015 1:CAS:528: DC%2BD2cXntV2hurw%3D 15336442 (Pubitemid 39158749)
28. T Utsunomiya M Okamoto S Wakiyama M Hashimoto K Fukuzawa T Ezaki, et al. 2007 A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease World J Gastroenterol 13 383 390 1:CAS:528:DC%2BD2sXitFGgt7g%3D 17230606
29. N Iizuka Y Hamamoto M Oka 2004 Predicting individual outcomes in hepatocellular carcinoma Lancet 364 1837 1839 10.1016/S0140-6736(04)17455-2 15555651 (Pubitemid 39536076)
30. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 4th ed. Tokyo: Kanahara Shuppan; 2000. p. 32-3.
31. S Ueno D Aoki T Maeda F Kubo H Hokotate Y Fukukura, et al. 2004 Preoperative assessment of multicentric occurrence in synchronous small and multiple hepatocellular carcinoma based on image-patterns and histological grading of non-cancerous region Hepatol Res 29 24 30 10.1016/j.hepres.2004.02. 003 15135343 (Pubitemid 38594508)
32. M Sakon K Umeshita H Nagano H Eguchi S Kishimoto A Miyamoto, et al. 2000 Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves Arch Surg 135 1456 1459 10.1001/archsurg.135. 12.1456 1:STN:280:DC%2BD3M7htVemsw%3D%3D 11115352
33. K Ikeda Y Arase S Saitoh M Kobayashi Y Suzuki F Suzuki, et al. 2000 Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor: a prospective randomized study of hepatitis C virus-related liver cancer Hepatology 32 228 232 10.1053/jhep.2000.9409 1:CAS:528:DC%2BD3cXlvVyjtrk%3D 10915728
34. Y Muto H Moriwaki M Ninomiya S Adachi A Saito KT Takasaki, et al. 1996 Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma N Engl J Med 334 1561 1567 10.1056/NEJM199606133342402 1:CAS:528:DyaK28XksVCgsLk%3D 8628336 (Pubitemid 26177483)
35. T Takayama T Sekine M Makuuchi S Yamasaki T Kosuge J Yamamoto, et al. 2000 Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial Lancet 356 802 807 10.1016/S0140-6736(00)02654-4 1:STN:280:DC%2BD3cvmvVSltg%3D%3D 11022927 (Pubitemid 30706677)
36. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
37. N Larsson B Segerman B Howell K Fridell L Cassimeris M Gullberg 1999 Op18/stathmin mediates multiple region-specific tubulin and microtubule- regulating activities J Cell Biol 146 1289 1302 10.1083/jcb.146.6.1289 1:CAS:528:DyaK1MXmt1Gns74%3D 10491392 (Pubitemid 29477696)
38. S Singer V Ehemann A Brauckhoff M Keith S Vreden P Schirmacher, et al. 2007 Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis Hepatology 46 759 768 10.1002/hep.21736 1:CAS:528:DC%2BD2sXhtFWhsrrP 17663418 (Pubitemid 47436122)
39. M Malz A Weber S Singer V Riehmer M Bissinger MO Riener, et al. 2009 Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells Hepatology 50 1130 1139 10.1002/hep.23051 1:CAS:528:DC%2BD1MXhtlWlu7bM 19585652
40. QW Wong RW Lung PT Law PB Lai KY Chan KF To, et al. 2008 MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 257 269 10.1053/j.gastro.2008.04.003 1:CAS:528:DC%2BD1cXps1Wltbg%3D 18555017 (Pubitemid 351910680)
41. JN Vauthey GL Walsh G Vlastos GY Lauwers 2000 Importance of field cancerisation in clinical oncology Lancet Oncol 1 15 16 10.1016/S1470-2045(00) 00105-4 1:STN:280:DC%2BD387ntlyrsg%3D%3D 11905680
42. K Nishida S Mine T Utsunomiya H Inoue M Okamoto H Udagawa, et al. 2005 Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray Cancer Res 65 401 409 1:CAS:528: DC%2BD2MXns1KrsQ%3D%3D 15695380
43. H Yoshiji R Noguchi M Kitade K Kaji Y Ikenaka T Namisaki, et al. 2009 Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats J Gastroenterol 44 483 491 10.1007/s00535-009-0031-0 1:CAS:528:DC%2BD1MXlslCrtrY%3D 19319465